{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T15:10:40Z","timestamp":1790262640811,"version":"4.1.0"},"reference-count":63,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Ministry of Health, Labor, and Welfare, Japan"},{"DOI":"10.13039\/501100008880","name":"Kanae Foundation for the Promotion of Medical Science","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100008880","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Alumni Association of the Department of Medicine at Showa University"},{"name":"Nagao Memorial"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurobiology of Aging"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1016\/j.neurobiolaging.2011.10.015","type":"journal-article","created":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T23:05:30Z","timestamp":1322780730000},"page":"2172-2185","source":"Crossref","is-referenced-by-count":72,"title":["Effect of melatonin on \u03b1-synuclein self-assembly and cytotoxicity"],"prefix":"10.1016","volume":"33","author":[{"given":"Kenjiro","family":"Ono","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Mochizuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tokuhei","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoko","family":"Nihira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-ichi","family":"Takasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David B.","family":"Teplow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahito","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurobiolaging.2011.10.015_bib1","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0168-0102(98)00055-8","article-title":"Amyloid \u03b2 protein inhibits cellular MTT reduction not by suppression of mitochondrial succinate dehydrogenase but by acceleration of MTT formazan exocytosis in cultured rat cortical astrocytes","volume":"31","author":"Abe","year":"1998","journal-title":"Neurosci. Res"},{"key":"10.1016\/j.neurobiolaging.2011.10.015_bib2","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jmb.2005.10.071","article-title":"Secondary structure of \u03b1-synuclein oligomers: characterization by raman and atomic force microscopy","volume":"355","author":"Apetri","year":"2006","journal-title":"J. Mol. Biol"},{"key":"10.1016\/j.neurobiolaging.2011.10.015_bib3","first-page":"879","article-title":"Aggregation of \u03b1-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies","volume":"152","author":"Baba","year":"1998","journal-title":"Am. J. Pathol"},{"key":"10.1016\/j.neurobiolaging.2011.10.015_bib4","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0022-510X(03)00204-1","article-title":"Neuroprotective effect of citicoline in 6-hydroxydopamine-lesioned rats and in 6-hydroxydopamine-treated SH-SY5Y human neuroblastoma cells","volume":"215","author":"Barrachina","year":"2003","journal-title":"J. Neurol. Sci"},{"key":"10.1016\/j.neurobiolaging.2011.10.015_bib5","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/nature10324","article-title":"\u03b1-Synuclein occurs physiologically as a helically folded tetramer that resists aggregation","volume":"477","author":"Bartels","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.neurobiolaging.2011.10.015_bib6","doi-asserted-by":"crossref","first-page":"35176","DOI":"10.1074\/jbc.M102223200","article-title":"Amyloid \u03b2-protein oligomerization: prenucleation interactions revealed by photo-induced cross-linking of unmodified proteins","volume":"276","author":"Bitan","year":"2001","journal-title":"J. Biol. Chem"},{"key":"10.1016\/j.neurobiolaging.2011.10.015_bib7","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1021\/ar000214l","article-title":"Rapid photochemical cross-linking\u2014a new tool for studies of metastable, amyloidogenic protein assemblies","volume":"37","author":"Bitan","year":"2004","journal-title":"Acc. Chem. Res"},{"key":"10.1016\/j.neurobiolaging.2011.10.015_bib8","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1210\/jcem-72-4-819","article-title":"Sequential cerebrospinal fluid and plasma sampling in humans: 24-hour melatonin measurements in normal subjects and after peripheral sympathectomy","volume":"72","author":"Bruce","year":"1991","journal-title":"J. Clin. Endocrinol. Metab"},{"key":"10.1016\/j.neurobiolaging.2011.10.015_bib9","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1146\/annurev.neuro.26.010302.081142","article-title":"Protofibrils, pores, fibrils, and neurodegeneration: separating the responsible protein aggregates from the innocent bystanders","volume":"26","author":"Caughey","year":"2003","journal-title":"Annu. Rev. Neurosci"},{"key":"10.1016\/j.neurobiolaging.2011.10.015_bib10","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1038\/3311","article-title":"Accelerated in vitro fibril formation by a mutant \u03b1-synuclein linked to early-onset Parkinson disease","volume":"4","author":"Conway","year":"1998","journal-title":"Nat. Med"},{"key":"10.1016\/j.neurobiolaging.2011.10.015_bib11","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1021\/bi991447r","article-title":"Fibrils formed in vitro from \u03b1-synuclein and two mutant forms linked to Parkinson's disease are typical amyloid","volume":"39","author":"Conway","year":"2000","journal-title":"Biochemistry"},{"key":"10.1016\/j.neurobiolaging.2011.10.015_bib12","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1126\/science.1063522","article-title":"Kinetic stabilization of the \u03b1-synuclein protofibril by a dopamine-\u03b1-synuclein adduct","volume":"294","author":"Conway","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.neurobiolaging.2011.10.015_bib13","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1096\/fj.03-1449com","article-title":"Detection of oligomeric forms of \u03b1-synuclein protein in human plasma as a potential biomarker for Parkinson's disease","volume":"20","author":"El-Agnaf","year":"2006","journal-title":"FASEB J"},{"key":"10.1016\/j.neurobiolaging.2011.10.015_bib14","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1073\/pnas.92.3.763","article-title":"Apolipoprotein E is a kinetic but not a thermodynamic inhibitor of amyloid formation: implications for the pathogenesis and treatment of Alzheimer disease","volume":"92","author":"Evans","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neurobiolaging.2011.10.015_bib15","doi-asserted-by":"crossref","first-page":"6020","DOI":"10.1073\/pnas.96.11.6020","article-title":"Chemistry for the analysis of protein\u2013protein interactions: rapid and efficient cross-linking triggered by long wavelength light","volume":"96","author":"Fancy","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neurobiolaging.2011.10.015_bib16","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/35006074","article-title":"A Drosophila model of Parkinson's disease","volume":"404","author":"Feany","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.neurobiolaging.2011.10.015_bib17","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1097\/00005072-199603000-00001","article-title":"Neuropathology of Parkinson's disease","volume":"55","author":"Forno","year":"1996","journal-title":"J. Neuropathol. Exp. Neurol"},{"key":"10.1016\/j.neurobiolaging.2011.10.015_bib18","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0140-6736(05)79256-4","article-title":"Multiple-system atrophy: a new \u03b1-synuclein disease?","volume":"352","author":"Gai","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.neurobiolaging.2011.10.015_bib19","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2174\/157015909787602814","article-title":"Targeting the progression of Parkinson's disease","volume":"7","author":"George","year":"2009","journal-title":"Curr. Neuropharmacol"},{"key":"10.1016\/j.neurobiolaging.2011.10.015_bib20","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0896-6273(02)00682-7","article-title":"Neuronal \u03b1-synucleinopathy with severe movement disorder in mice expressing A53T human \u03b1-synuclein","volume":"34","author":"Giasson","year":"2002","journal-title":"Neuron"},{"key":"10.1016\/j.neurobiolaging.2011.10.015_bib21","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/S0022-510X(98)00304-9","article-title":"Consensus statement on the diagnosis of multiple system atrophy","volume":"163","author":"Gilman","year":"1999","journal-title":"J. Neurol. Sci"},{"key":"10.1016\/j.neurobiolaging.2011.10.015_bib22","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1515\/CCLM.2001.047","article-title":"Parkinson's disease and other \u03b1-synucleinopathies","volume":"39","author":"Goedert","year":"2001","journal-title":"Clin. Chem. Lab. Med"},{"key":"10.1016\/j.neurobiolaging.2011.10.015_bib23","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/S0006-8993(97)00093-0","article-title":"Neurotoxic effects of papaverine, tetrahydropapaverine and dimethoxyphenylethylamine on dopaminergic neurons in ventral mesencephalic-striatal co-culture","volume":"754","author":"Goto","year":"1997","journal-title":"Brain Res"},{"key":"10.1016\/j.neurobiolaging.2011.10.015_bib24","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1600-079X.2006.00390.x","article-title":"Melatonin inhibits maneb-induced aggregation of \u03b1-synuclein in rat pheochromocytoma cells","volume":"42","author":"Ishido","year":"2007","journal-title":"J. Pineal Res"},{"key":"10.1016\/j.neurobiolaging.2011.10.015_bib25","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1600-079X.1998.tb00371.x","article-title":"Melatonin increases gene expression for antioxidant enzymes in rat brain cortex","volume":"24","author":"Kotler","year":"1998","journal-title":"J. Pineal Res"},{"key":"10.1016\/j.neurobiolaging.2011.10.015_bib26","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/S0022-2836(02)00735-0","article-title":"\u03b1-synuclein, especially the Parkinson's disease-associated mutants, forms pore-like annular and tubular protofibrils","volume":"322","author":"Lashuel","year":"2002","journal-title":"J. Mol. Biol"},{"key":"10.1016\/j.neurobiolaging.2011.10.015_bib27","doi-asserted-by":"crossref","first-page":"8968","DOI":"10.1073\/pnas.132197599","article-title":"Human alpha-synuclein-harboring familial Parkinson's disease-linked Ala-53 \u2013> Thr mutation causes neurodegenerative disease with alpha-synuclein aggregation in transgenic mice","volume":"99","author":"Lee","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neurobiolaging.2011.10.015_bib28","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1002\/pro.5560020312","article-title":"Thioflavine T interaction with synthetic Alzheimer's disease \u03b2-amyloid peptides: detection of amyloid aggregation in solution","volume":"2","author":"LeVine","year":"1993","journal-title":"Protein Sci"},{"key":"10.1016\/j.neurobiolaging.2011.10.015_bib29","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/S0076-6879(99)09020-5","article-title":"Quantification of \u03b2-sheet amyloid fibril structures with thioflavin T","volume":"309","author":"LeVine","year":"1999","journal-title":"Methods Enzymol"},{"key":"10.1016\/j.neurobiolaging.2011.10.015_bib30","doi-asserted-by":"crossref","first-page":"385","DOI":"10.2174\/092986606775974384","article-title":"The early events of \u03b1-synuclein oligomerization revealed by photo-induced cross-linking","volume":"13","author":"Li","year":"2006","journal-title":"Protein Pept. Lett"},{"key":"10.1016\/j.neurobiolaging.2011.10.015_bib31","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/j.chembiol.2004.08.025","article-title":"Rifampicin inhibits \u03b1-synuclein fibrillation and disaggregates fibrils","volume":"11","author":"Li","year":"2004","journal-title":"Chem. Biol"},{"key":"10.1016\/j.neurobiolaging.2011.10.015_bib32","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1600-079X.2007.00456.x","article-title":"Melatonin attenuates arsenite-induced apoptosis in rat brain: involvement of mitochondrial and endoplasmic reticulum pathways and aggregation of \u03b1-synuclein","volume":"43","author":"Lin","year":"2007","journal-title":"J. Pineal Res"},{"key":"10.1016\/j.neurobiolaging.2011.10.015_bib33","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1034\/j.1600-079X.2003.00041.x","article-title":"Melatonin, xanthurenic acid, resveratrol, EGCG, vitamin C and \u03b1-lipoic acid differentially reduce oxidative DNA damage induced by Fenton reagents: a study of their individual and synergistic actions","volume":"34","author":"L\u00f3pez-Burillo","year":"2003","journal-title":"J. Pineal Res"},{"key":"10.1016\/j.neurobiolaging.2011.10.015_bib34","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1046\/j.1471-4159.2003.01654.x","article-title":"Melatonin increases survival and inhibits oxidative and amyloid pathology in a transgenic model of Alzheimer's disease","volume":"85","author":"Matsubara","year":"2003","journal-title":"J. Neurochem"},{"key":"10.1016\/j.neurobiolaging.2011.10.015_bib35","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1212\/01.wnl.0000187889.17253.b1","article-title":"Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium","volume":"65","author":"McKeith","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2011.10.015_bib36","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0304-3940(94)90271-2","article-title":"Apoptosis is induced by 1-methyl-4-phenylpyridinium ion (MPP+) in ventral mesencephalic-striatal co-culture in rat","volume":"170","author":"Mochizuki","year":"1994","journal-title":"Neurosci. Lett"},{"key":"10.1016\/j.neurobiolaging.2011.10.015_bib37","first-page":"374","article-title":"First-order kinetic model of Alzheimer's \u03b2-amyloid fibril extension in vitro","volume":"74","author":"Naiki","year":"1996","journal-title":"Lab. Invest"},{"key":"10.1016\/j.neurobiolaging.2011.10.015_bib38","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1007\/s11064-008-9876-5","article-title":"Neuroprotective effects of chalcones from Myracrodruon urundeuva on 6-hydroxydopamine-induced cytotoxicity in rat mesencephalic cells","volume":"34","author":"Nobre-J\u00fanior","year":"2009","journal-title":"Neurochem. Res"},{"key":"10.1016\/j.neurobiolaging.2011.10.015_bib39","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1002\/jnr.21271","article-title":"Anti-fibrillogenic and fibril-destabilizing activities of anti-Parkinsonian agents for \u03b1-synuclein fibrils in vitro","volume":"85","author":"Ono","year":"2007","journal-title":"J. Neurosci. Res"},{"key":"10.1016\/j.neurobiolaging.2011.10.015_bib40","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1471-4159.2006.03707.x","article-title":"Antioxidant compounds have potent anti-fibrillogenic and fibril-destabilizing effects for \u03b1-synuclein fibrils in vitro","volume":"97","author":"Ono","year":"2006","journal-title":"J. Neurochem"},{"key":"10.1016\/j.neurobiolaging.2011.10.015_bib41","doi-asserted-by":"crossref","first-page":"e1867","DOI":"10.1371\/journal.pone.0001867","article-title":"Formation of toxic oligomeric \u03b1-synuclein species in living cells","volume":"3","author":"Outeiro","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.neurobiolaging.2011.10.015_bib42","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1093\/brain\/awn349","article-title":"Detection of elevated levels of soluble \u03b1-synuclein oligomers in post-mortem brain extracts from patients with dementia with Lewy bodies","volume":"132","author":"Paleologou","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.neurobiolaging.2011.10.015_bib43","doi-asserted-by":"crossref","first-page":"7185","DOI":"10.1074\/jbc.273.13.7185","article-title":"Inhibition of Alzheimer \u03b2-fibrillogenesis by melatonin","volume":"273","author":"Pappolla","year":"1998","journal-title":"J. Biol. Chem"},{"key":"10.1016\/j.neurobiolaging.2011.10.015_bib44","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1080\/07420520500482074","article-title":"Melatonin in the multi-oscillatory mammalian circadian world","volume":"23","author":"P\u00e9vet","year":"2006","journal-title":"Chronobiol. Int"},{"key":"10.1016\/j.neurobiolaging.2011.10.015_bib45","doi-asserted-by":"crossref","first-page":"14995","DOI":"10.1021\/bi0114269","article-title":"Melatonin reverses the profibrillogenic activity of apolipoprotein E4 on the Alzheimer amyloid A\u03b2 peptide","volume":"40","author":"Poeggeler","year":"2001","journal-title":"Biochemistry"},{"key":"10.1016\/j.neurobiolaging.2011.10.015_bib46","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1111\/j.1471-4159.2004.02533.x","article-title":"Annular \u03b1-synuclein species from purified multiple system atrophy inclusions","volume":"90","author":"Pountney","year":"2004","journal-title":"J. Neurochem"},{"key":"10.1016\/j.neurobiolaging.2011.10.015_bib47","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1016\/S0024-3205(97)00030-1","article-title":"Pharmacological actions of melatonin in oxygen radical pathophysiology","volume":"60","author":"Reiter","year":"1997","journal-title":"Life Sci"},{"key":"10.1016\/j.neurobiolaging.2011.10.015_bib48","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1210\/edrv-12-2-151","article-title":"Pineal melatonin: cell biology of its synthesis and of its physiological interactions","volume":"12","author":"Reiter","year":"1991","journal-title":"Endocr. Rev"},{"key":"10.1016\/j.neurobiolaging.2011.10.015_bib49","first-page":"71","article-title":"Protective effects of melatonin on cortico-hippocampal neurotoxicity induced by amyloid \u03b2-peptide 25\u201335","volume":"23","author":"Shen","year":"2002","journal-title":"Acta Pharmacol. Sin"},{"key":"10.1016\/j.neurobiolaging.2011.10.015_bib50","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1034\/j.1600-079x.2002.1819.x","article-title":"The protective effects of melatonin from oxidative damage induced by amyloid \u03b2-peptide 25\u201335 in middle-aged rats","volume":"32","author":"Shen","year":"2002","journal-title":"J. Pineal Res"},{"key":"10.1016\/j.neurobiolaging.2011.10.015_bib51","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1034\/j.1600-079x.2002.1o839.x","article-title":"Melatonin blocks rat hippocampal neuronal apoptosis induced by amyloid \u03b2-peptide 25\u201335","volume":"32","author":"Shen","year":"2002","journal-title":"J. Pineal Res"},{"key":"10.1016\/j.neurobiolaging.2011.10.015_bib52","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0304-3940(98)00504-7","article-title":"Filamentous \u03b1-synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies","volume":"251","author":"Spillantini","year":"1998","journal-title":"Neurosci. Lett"},{"key":"10.1016\/j.neurobiolaging.2011.10.015_bib53","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/BF03033887","article-title":"Role of melatonin in neurodegenerative diseases","volume":"7","author":"Srinivasan","year":"2005","journal-title":"Neurotox. Res"},{"key":"10.1016\/j.neurobiolaging.2011.10.015_bib54","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1111\/j.1471-4159.2004.02397.x","article-title":"Dopamine transporter-mediated cytotoxicity of \u03b2-carbolinium derivatives related to Parkinson's disease: relationship to transporter-dependent uptake","volume":"89","author":"Storch","year":"2004","journal-title":"J. Neurochem"},{"key":"10.1016\/j.neurobiolaging.2011.10.015_bib55","doi-asserted-by":"crossref","first-page":"7614","DOI":"10.1074\/jbc.M408714200","article-title":"Inhibition of heparin-induced tau filament formation by phenothiazines, polyphenols, and porphyrins","volume":"280","author":"Taniguchi","year":"2005","journal-title":"J. Biol. Chem"},{"key":"10.1016\/j.neurobiolaging.2011.10.015_bib56","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1002\/jnr.22201","article-title":"Melatonin treatment potentiates neurodegeneration in a rat rotenone Parkinson's disease model","volume":"88","author":"Tapias","year":"2009","journal-title":"J. Neurosci. Res"},{"key":"10.1016\/j.neurobiolaging.2011.10.015_bib57","doi-asserted-by":"crossref","first-page":"e3135","DOI":"10.1371\/journal.pone.0003135","article-title":"Mechanisms of hybrid oligomer formation in the pathogenesis of combined Alzheimer's and Parkinson's diseases","volume":"3","author":"Tsigelny","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.neurobiolaging.2011.10.015_bib58","doi-asserted-by":"crossref","first-page":"7871","DOI":"10.1021\/bi030086j","article-title":"Zeroing in on the pathogenic form of \u03b1-synuclein and its mechanism of neurotoxicity in Parkinson's disease","volume":"42","author":"Volles","year":"2003","journal-title":"Biochemistry"},{"key":"10.1016\/j.neurobiolaging.2011.10.015_bib59","doi-asserted-by":"crossref","first-page":"7812","DOI":"10.1021\/bi0102398","article-title":"Vesicle permeabilization by protofibrillar \u03b1-synuclein: implications for the pathogenesis and treatment of Parkinson's disease","volume":"40","author":"Volles","year":"2001","journal-title":"Biochemistry"},{"key":"10.1016\/j.neurobiolaging.2011.10.015_bib60","doi-asserted-by":"crossref","first-page":"19509","DOI":"10.1074\/jbc.274.28.19509","article-title":"\u03b1-synuclein fibrillogenesis is nucleation-dependent","volume":"274","author":"Wood","year":"1999","journal-title":"J. Biol. Chem"},{"key":"10.1016\/j.neurobiolaging.2011.10.015_bib61","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1038\/nm0602-600","article-title":"Dopamine-dependent neurotoxicity of \u03b1-synuclein: a mechanism for selective neurodegeneration in Parkinson disease","volume":"8","author":"Xu","year":"2002","journal-title":"Nat. Med"},{"key":"10.1016\/j.neurobiolaging.2011.10.015_bib62","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.neuron.2005.01.032","article-title":"Mouse model of multiple system atrophy \u03b1-synuclein expression in oligodendrocytes causes glial and neuronal degeneration","volume":"45","author":"Yazawa","year":"2005","journal-title":"Neuron"},{"key":"10.1016\/j.neurobiolaging.2011.10.015_bib63","doi-asserted-by":"crossref","first-page":"26846","DOI":"10.1074\/jbc.M403129200","article-title":"The flavonoid baicalein inhibits fibrillation of \u03b1-synuclein and disaggregates existing fibrils","volume":"279","author":"Zhu","year":"2004","journal-title":"J. Biol. Chem"}],"container-title":["Neurobiology of Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458011004313?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458011004313?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,7]],"date-time":"2020-05-07T01:16:33Z","timestamp":1588814193000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197458011004313"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9]]},"references-count":63,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["S0197458011004313"],"URL":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2011.10.015","relation":{},"ISSN":["0197-4580"],"issn-type":[{"value":"0197-4580","type":"print"}],"subject":[],"published":{"date-parts":[[2012,9]]}}}